In recent years, particularly after the pandemic, the demand for effective antibacterial and antiviral solutions has surged. These solutions are increasingly utilized in diverse settings, including residential spaces, educational institutions, public areas, and transportation systems. Thus, it is anticipated that the demand for antimicrobial and antiviral products will continue to grow. Despite their utility, Traditional antimicrobial and antiviral technologies face key limitations: copper provides fast action but lacks durability due to oxidation and has limited coverage; silver ions are more durable and versatile but act more slowly; and photocatalysts offer durability but depend on light availability. These challenges underscore the need for a technology that is fast-acting, durable, and versatile across various environments.

To address these challenges, the technology owner has developed a hybrid photocatalytic film with enhanced antibacterial and antiviral properties. This solution combines the photocatalytic activity of copper suboxide and titanium dioxide with visible light responsiveness to effectively denature membrane proteins on virus surfaces, thereby reducing their infectivity.  Additionally, the technology incorporates a film-based manufacturing process, providing a more efficient alternative to traditional paint-based approaches.

The technology owner is actively seeking R&D collaborations and licensing opportunities with industry partners interested in implementing this film in various applications.